封面
市场调查报告书
商品编码
1442014

阴道吊带市场- 按产品(经闭孔、无张力阴道吊带、迷你吊带)、失禁类型(压力型、急迫型、混合型)、类型(中尿道型、传统型)、最终用途(医院、诊所、 ASC) - 全球预测, 2024 - 2032

Vaginal Slings Market - By Product (Transobturator, Tension-free Vaginal Tape, Mini-Slings), Incontinence type (Stress, Urge, Mixed), Type (Midurethral, Traditional), End-use (Hospitals, Clinics, ASC) - Global Forecast, 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 150 Pages | 商品交期: 2-3个工作天内

价格
简介目录

由于人们对治疗选择的认识不断提高,加上手术技术和材料的进步,全球阴道吊带市场将从 2024 年到 2032 年以 9% 的CAGR增长。随着患者对微创手术及其益处的了解越来越多,对骨盆底疾病有效解决方案的需求也随之增加。此外,吊带设计和材料的不断创新可以提高患者的治疗效果和满意度。随着医疗保健提供者越来越多地采用这些技术以及寻求改善生活品质的患者,阴道吊带产业将显着扩张。

例如,2022年10月,一种治疗女性压力性尿失禁的创新疗法Urolon在英国首次亮相。这种持续时间约为 20 分钟的微创治疗适合在医院或诊所进行。此次推出扩大了女性压力性尿失禁的治疗选择范围,有助于市场的多元化和成长。

阴道吊带产业根据产品、失禁类型和地区进行分类。

由于其治疗压力性尿失禁和骨盆腔器官脱垂的功效,到 2032 年,无张力阴道胶带细分市场将占据显着的市场份额。无张力阴道胶带手术侵入性极小,成功率高,提供患者有效且持久的解决方案。此外,技术进步改进了胶带设计和材料,改善了患者的治疗效果。随着医疗保健提供者越来越多地采用这种方法,并且患者寻求微创治疗方案,无张力阴道吊带细分市场将在阴道吊带行业中占据最大份额。

由于其针对压力性尿失禁和急迫性尿失禁的多功能治疗方法,到 2032 年,混合性尿失禁领域的阴道吊带市占率将大幅上升。由于大量患者出现混合症状,因此对有效、全面的解决方案的需求很高。吊带设计的技术进步专门针对混合性失禁,为患者提供更好的生活品质。随着医疗保健提供者优先考虑量身定制的治疗方案以及患者寻求全面护理,混合性失禁细分市场将成为阴道吊带市场前景的重要参与者。

受尿失禁治疗意识增强、老年人口增加和医疗基础设施改善等因素的推动,亚太地区阴道吊带产业到 2032 年将录得显着的复合CAGR。此外,该地区庞大的人口基数和不断增长的可支配收入也促进了市场的成长。技术进步和有利的政府措施将进一步推动阴道吊带术在该地区的采用。综合这些因素,亚太地区将成为阴道吊带产业的关键贡献者。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 尿失禁(UI)盛行率增加
      • 老年人口不断增加
      • 手术技术不断进步
      • 对骨盆底疾病及其治疗方案的认识不断提高
    • 产业陷阱与挑战
      • 阴道吊带手术费用高
      • 安全性和有效性问题
  • 成长潜力分析
  • 监管环境
  • 技术景观
  • 波特的分析
  • PESTEL分析
  • 报销场景
  • 未来市场趋势
  • 缺口分析

第 4 章:竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章:市场估计与预测:按产品分类,2018 年 - 2032 年

  • 主要趋势
  • 经闭孔吊带
  • 无张力阴道吊带
  • 迷你吊带

第 6 章:市场估计与预测:按失禁类型,2018 年 - 2032 年

  • 主要趋势
  • 压力性尿失禁
  • 急迫性尿失禁
  • 混合性失禁

第 7 章:市场估计与预测:按类型,2018 - 2032

  • 主要趋势
  • 尿道中段吊带
  • 传统吊带

第 8 章:市场估计与预测:按最终用途,2018 - 2032 年

  • 主要趋势
  • 医院
  • 诊所
  • 门诊手术中心

第 9 章:市场估计与预测:按地区划分,2018 年 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋
    • 中东和非洲其他地区

第 10 章:公司简介

  • A.M.I. GmbH
  • B. Braun Melsungen AG
  • Betatech Medical
  • Boston Scientific Corporation
  • Caldera Medical
  • Coloplast Corp
  • Cousin Surgery
  • Johnson & Johnson Services, Inc.
  • Lotus Surgicals
  • Neomedic International
  • Promedon S.A.
  • UroCure
简介目录
Product Code: 3335

Global Vaginal Slings Market will expand at a 9% CAGR from 2024 to 2032, attributed to increasing awareness of treatment options coupled with advancements in surgical techniques and materials. As patients become more informed about minimally invasive procedures and their benefits, demand for effective solutions for pelvic floor disorders rises. Moreover, continuous innovation in sling design and materials enhances patient outcomes and satisfaction. With healthcare providers increasingly adopting these techniques and patients seeking improved quality of life, the vaginal slings industry will expand significantly.

For instance, in October 2022, Urolon, an innovative therapy for female stress urinary incontinence, debuted in the UK. This minimally invasive treatment with a duration of approximately 20 minutes is suitable for administration in either a hospital or clinic setting. The launch expands the range of treatment options available for female stress urinary incontinence, contributing to the diversification and growth of the market.

The vaginal slings industry is classified based on product, incontinence type, and region.

The tension-free vaginal tape segment will capture noteworthy market share through 2032, propelled by its efficacy in treating stress urinary incontinence and pelvic organ prolapse. With minimal invasiveness and high success rates, tension-free vaginal tape procedures offer patients effective and long-lasting solutions. Moreover, technological advancements have improved tape design and materials, enhancing patient outcomes. As healthcare providers increasingly adopt this method and patients seek minimally invasive treatment options, the tension-free vaginal tape segment will secure the largest share in the vaginal slings industry.

The vaginal slings market share from the mixed incontinence segment will experience a substantial upswing by 2032 due to its versatile treatment approach addressing both stress and urge urinary incontinence. With a significant patient population experiencing mixed symptoms, the demand for effective and comprehensive solutions is high. Technological advancements in sling design cater specifically to mixed incontinence, offering patients an improved quality of life. As healthcare providers prioritize tailored treatment options and patients seek comprehensive care, the mixed incontinence segment will stand as a prominent player in the vaginal slings market outlook.

Asia Pacific vaginal slings industry will record a remarkable CAGR by 2032, fueled by factors such as increasing awareness of urinary incontinence treatments, a rising geriatric population, and improving healthcare infrastructure. Moreover, the region's large population base and growing disposable income contribute to market growth. Technological advancements and favorable government initiatives will further propel the adoption of vaginal sling procedures in the region. With these factors combined, Asia Pacific will emerge as the pivotal contributor to the vaginal slings industry.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Base estimates & workings
  • 1.5 Forecast calculations
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of urinary incontinence (UI)
      • 3.2.1.2 Growing geriatric population
      • 3.2.1.3 Increasing advancements in surgical techniques
      • 3.2.1.4 Rising awareness of pelvic floor disorders and their treatment options
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of vaginal sling procedure
      • 3.2.2.2 Safety and efficacy concerns
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis
  • 3.8 Reimbursement scenario
  • 3.9 Future market trends
  • 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Transobturator slings
  • 5.3 Tension-free vaginal tape slings
  • 5.4 Mini-slings

Chapter 6 Market Estimates and Forecast, By Incontinence Type, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Stress incontinence
  • 6.3 Urge incontinence
  • 6.4 Mixed incontinence

Chapter 7 Market Estimates and Forecast, By Type, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Midurethral sling
  • 7.3 Traditional sling

Chapter 8 Market Estimates and Forecast, By End-use, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Clinics
  • 8.4 Ambulatory surgical centers

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 A.M.I. GmbH
  • 10.2 B. Braun Melsungen AG
  • 10.3 Betatech Medical
  • 10.4 Boston Scientific Corporation
  • 10.5 Caldera Medical
  • 10.6 Coloplast Corp
  • 10.7 Cousin Surgery
  • 10.8 Johnson & Johnson Services, Inc.
  • 10.9 Lotus Surgicals
  • 10.10 Neomedic International
  • 10.11 Promedon S.A.
  • 10.12 UroCure